Skip to main content
SpringerLink
Log in

Oral ibuprofen cost effective in neonates with patent ductus arteriosis

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2019/2020 US dollars

Reference

  • Abushanab D, et al. Cost-effectiveness of Oral Versus Intravenous Ibuprofen Therapy in Preterm Infants With Patent Ductus Arteriosus in the Neonatal Intensive Care Setting: A Cohort-based Study. Clinical Therapeutics : 8 Jan 2021. Available from: URL: http://doi.org/10.1016/j.clinthera.2020.12.004

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Oral ibuprofen cost effective in neonates with patent ductus arteriosis. PharmacoEcon Outcomes News 870, 19 (2021). https://doi.org/10.1007/s40274-021-7422-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7422-8

Search

Navigation